Andrew P. Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andrew P. Smith has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Brandon A. Berryhill
Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
5 shared publications - Bruce R. Levin
Department of Biology, Emory University
4 shared publications - Fernando Baquero
Department of Microbiology, Ramón y Cajal University Hospital, Ramón y Cajal Institute for Health Research (IRYCIS), Madrid, Spain
4 shared publications - Joshua A. Manuel
Section on Infectious Diseases, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem
4 shared publications - Teresa Gil-Gil
Department of Biology, Emory University
4 shared publications - Alysha S. Ismail
Department of Biology, Emory University
2 shared publications
Latest Publications
- Open Access
- 16 May 2026
- Published by Elsevier in SSRN Electronic Journal
Technostress and Employee Well-being Across Maritime Roles: A Multi-group Study
The rapid digitisation of maritime supply chains has intensified technology-related demands, raising concerns about employee well-being. Despite growing research on technostress, evidence from the maritime sector across occupational groups remains limited. Drawing on the Demands-Resources-Individual Effects (DRIVE) model, this cross-sectional study examined relationships between technostress and well-being among maritime professionals, including seafarers, port operators, and intermediaries. Technostress was measured using the Technostress Creators Scale, and well-being was measured using the Well-being Process Questionnaire. Principal component analysis of the five technostress subscales yielded a single factor (55.0% of variance), supporting a total technostress score (TotTech). Moreover, item-level analysis recovered five rotated factors that correlated almost perfectly with the original subscales, justifying the parallel use of subscale scores. Hierarchical regression showed that TotTech negatively predicted combined well-being (β = -.275, p < .001) and positively predicted negative well-being (β = .333, p < .001) after controlling for workplace predictors. Among the five subscales, only techno-invasion significantly predicted negative well-being (p < .001) and combined well-being (p = .004). Both TotTech and techno-invasion remained independent predictors after the combined psychosocial score was added. Seafarers reported the highest techno-overload, intermediaries the highest techno-invasion, and port operators the lowest scores. Technostress increased with education and work experience and varied by ship type, with no gender difference. Findings highlight techno-invasion as the principal well-being-relevant technostressor.
- 16 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessTechnostress and Employee Well-being Across Maritime Roles: A Multi-group Study
The rapid digitisation of maritime supply chains has intensified technology-related demands, raising concerns about employee well-being. Despite growing research on technostress, evidence from the maritime sector across occupational groups remains limited. Drawing on the Demands-Resources-Individual Effects (DRIVE) model, this cross-sectional study examined relationships between technostress and well-being among maritime professionals, including seafarers, port operators, and intermediaries. Technostress was measured using the Technostress Creators Scale, and well-being was measured using the Well-being Process Questionnaire. Principal component analysis of the five technostress subscales yielded a single factor (55.0% of variance), supporting a total technostress score (TotTech). Moreover, item-level analysis recovered five rotated factors that correlated almost perfectly with the original subscales, justifying the parallel use of subscale scores. Hierarchical regression showed that TotTech negatively predicted combined well-being (β = -.275, p < .001) and positively predicted negative well-being (β = .333, p < .001) after controlling for workplace predictors. Among the five subscales, only techno-invasion significantly predicted negative well-being (p < .001) and combined well-being (p = .004). Both TotTech and techno-invasion remained independent predictors after the combined psychosocial score was added. Seafarers reported the highest techno-overload, intermediaries the highest techno-invasion, and port operators the lowest scores. Technostress increased with education and work experience and varied by ship type, with no gender difference. Findings highlight techno-invasion as the principal well-being-relevant technostressor.
- Open Access
- 1 April 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (4)
The tradeoffs between persistence and mutation rates at sub-inhibitory antibiotic concentrations in Staphylococcus aureus
The rational design of the antibiotic treatment of bacterial infections employs these drugs to reach concentrations that exceed the minimum needed to prevent the replication of the target bacteria. However, within a treated patient, spatial and physiological heterogeneity promotes antibiotic gradients such that the concentration of antibiotics at specific sites is below the minimum needed to inhibit bacterial growth. Here, we investigate the effects of sub-inhibitory antibiotic concentrations on three parameters central to bacterial infection and the success of antibiotic treatment, using in vitro experiments with Staphylococcus aureus and mathematical and computer-simulation models. Our results, using drugs of six different classes, demonstrate that exposure to sub-inhibitory antibiotic concentrations alters bacterial growth dynamics, increases the mutation rate to antibiotic resistance, and decreases the production of persister cells thereby reducing persistence levels. Understanding this trade-off between mutation rates and persistence levels resulting from sub-inhibitory antibiotic exposure is crucial for optimizing, and mitigating the failure of, antibiotic therapy. IMPORTANCE: Much of the research on antibiotics and antibiotic treatment has focused on drug concentrations sufficient to prevent the growth of bacteria. These concentrations, however, are not always reached everywhere in the body. Here, we look at the effects of exposure to these low concentrations of antibiotics on the common clinically important pathogen Staphylococcus aureus . We confirm a previous finding that sub-inhibitory antibiotic exposure decreases the total growth and the growth rate of the bacteria. Moreover, we demonstrate that the level of persistence, an important mechanism for bacteria to survive antibiotics, is decreased due to sub-inhibitory exposure. However, we find that the rate of generation of resistant mutants is substantially increased. Taken together, these results reveal an important trade-off that emerges as a consequence of bacteria being exposed to sub-inhibitory concentrations of antibiotics.
- 1 April 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (4)
Open AccessThe tradeoffs between persistence and mutation rates at sub-inhibitory antibiotic concentrations in Staphylococcus aureus
The rational design of the antibiotic treatment of bacterial infections employs these drugs to reach concentrations that exceed the minimum needed to prevent the replication of the target bacteria. However, within a treated patient, spatial and physiological heterogeneity promotes antibiotic gradients such that the concentration of antibiotics at specific sites is below the minimum needed to inhibit bacterial growth. Here, we investigate the effects of sub-inhibitory antibiotic concentrations on three parameters central to bacterial infection and the success of antibiotic treatment, using in vitro experiments with Staphylococcus aureus and mathematical and computer-simulation models. Our results, using drugs of six different classes, demonstrate that exposure to sub-inhibitory antibiotic concentrations alters bacterial growth dynamics, increases the mutation rate to antibiotic resistance, and decreases the production of persister cells thereby reducing persistence levels. Understanding this trade-off between mutation rates and persistence levels resulting from sub-inhibitory antibiotic exposure is crucial for optimizing, and mitigating the failure of, antibiotic therapy. IMPORTANCE: Much of the research on antibiotics and antibiotic treatment has focused on drug concentrations sufficient to prevent the growth of bacteria. These concentrations, however, are not always reached everywhere in the body. Here, we look at the effects of exposure to these low concentrations of antibiotics on the common clinically important pathogen Staphylococcus aureus . We confirm a previous finding that sub-inhibitory antibiotic exposure decreases the total growth and the growth rate of the bacteria. Moreover, we demonstrate that the level of persistence, an important mechanism for bacteria to survive antibiotics, is decreased due to sub-inhibitory exposure. However, we find that the rate of generation of resistant mutants is substantially increased. Taken together, these results reveal an important trade-off that emerges as a consequence of bacteria being exposed to sub-inhibitory concentrations of antibiotics.
- Open Access
- 6 May 2024
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 45 (9) , 1050-1056
A bacteriophage-based validation of a personal protective equipment doffing procedure to be used with high-consequence pathogens
Objective: To determine if the high-level personal protective equipment used in the treatment of high-consequence infectious diseases is effective at stopping the spread of pathogens to healthcare personnel (HCP) while doffing.Background: Personal protective equipment (PPE) is fundamental to the safety of HCPs. HCPs treating patients with high-consequence infectious diseases use several layers of PPE, forming complex protective ensembles. With high-containment PPE, step-by-step procedures are often used for donning and doffing to minimize contamination risk to the HCP, but these procedures are rarely empirically validated and instead rely on following infection prevention best practices.Methods: A doffing protocol video for a high-containment PPE ensemble was evaluated to determine potential contamination pathways. These potential pathways were tested using fluorescence and genetically marked bacteriophages.Results: The experiments revealed existing protocols permit contamination pathways allowing for transmission of bacteriophages to HCPs. Updates to the doffing protocols were generated based on the discovered contamination pathways. This updated doffing protocol eliminated the movement of viable bacteriophages from the outside of the PPE to the skin of the HCP.Conclusions: Our results illustrate the need for quantitative, scientific investigations of infection prevention practices, such as doffing PPE.
- 6 May 2024
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 45 (9) , 1050-1056
Open AccessA bacteriophage-based validation of a personal protective equipment doffing procedure to be used with high-consequence pathogens
Objective: To determine if the high-level personal protective equipment used in the treatment of high-consequence infectious diseases is effective at stopping the spread of pathogens to healthcare personnel (HCP) while doffing.Background: Personal protective equipment (PPE) is fundamental to the safety of HCPs. HCPs treating patients with high-consequence infectious diseases use several layers of PPE, forming complex protective ensembles. With high-containment PPE, step-by-step procedures are often used for donning and doffing to minimize contamination risk to the HCP, but these procedures are rarely empirically validated and instead rely on following infection prevention best practices.Methods: A doffing protocol video for a high-containment PPE ensemble was evaluated to determine potential contamination pathways. These potential pathways were tested using fluorescence and genetically marked bacteriophages.Results: The experiments revealed existing protocols permit contamination pathways allowing for transmission of bacteriophages to HCPs. Updates to the doffing protocols were generated based on the discovered contamination pathways. This updated doffing protocol eliminated the movement of viable bacteriophages from the outside of the PPE to the skin of the HCP.Conclusions: Our results illustrate the need for quantitative, scientific investigations of infection prevention practices, such as doffing PPE.
- Open Access
The Tradeoffs Between Persistence and Mutation Rates at Sub-Inhibitory Antibiotic Concentrations in Staphylococcus aureus
The rational design of the antibiotic treatment of bacterial infections employs these drugs to reach concentrations that exceed the minimum needed to prevent the replication of the target bacteria. However, within a treated patient, spatial and physiological heterogeneity promotes antibiotic gradients such that the concentration of antibiotics at specific sites is below the minimum needed to inhibit bacterial growth. Here, we investigate the effects of sub-inhibitory antibiotic concentrations on three parameters central to bacterial infection and the success of antibiotic treatment, using in vitro experiments with Staphylococcus aureus and mathematical-computer simulation models. Our results, using drugs of six different classes, demonstrate that exposure to sub-inhibitory antibiotic concentrations not only alters the dynamics of bacterial growth but also increases the mutation rate to antibiotic resistance and decreases the rate of production of persister cells thereby reducing the persistence level. Understanding this trade-off between mutation rates and persistence levels resulting from sub-inhibitory antibiotic exposure is crucial for optimizing, and mitigating the failure of, antibiotic therapy.
Open AccessThe Tradeoffs Between Persistence and Mutation Rates at Sub-Inhibitory Antibiotic Concentrations in Staphylococcus aureus
The rational design of the antibiotic treatment of bacterial infections employs these drugs to reach concentrations that exceed the minimum needed to prevent the replication of the target bacteria. However, within a treated patient, spatial and physiological heterogeneity promotes antibiotic gradients such that the concentration of antibiotics at specific sites is below the minimum needed to inhibit bacterial growth. Here, we investigate the effects of sub-inhibitory antibiotic concentrations on three parameters central to bacterial infection and the success of antibiotic treatment, using in vitro experiments with Staphylococcus aureus and mathematical-computer simulation models. Our results, using drugs of six different classes, demonstrate that exposure to sub-inhibitory antibiotic concentrations not only alters the dynamics of bacterial growth but also increases the mutation rate to antibiotic resistance and decreases the rate of production of persister cells thereby reducing the persistence level. Understanding this trade-off between mutation rates and persistence levels resulting from sub-inhibitory antibiotic exposure is crucial for optimizing, and mitigating the failure of, antibiotic therapy.
- Open Access
The Evolution of Heteroresistance via Small Colony Variants in Escherichia coli Following Long Term Exposure to Bacteriostatic Antibiotics
Traditionally, bacteriostatic antibiotics are agents able to arrest bacterial growth. Despite being traditionally viewed as unable to kill bacterial cells, when they are used clinically the outcome of these drugs is frequently as effective as when a bactericidal drug is used. We explore the dynamics of Escherichia coli after exposure to two ribosome-targeting bacteriostatic antibiotics, chloramphenicol and azithromycin, for thirty days. The results of our experiments provide evidence that bacteria exposed to these drugs replicate, evolve, and generate a sub-population of small colony variants (SCVs) which are resistant to multiple drugs. These SCVs contribute to the evolution of heteroresistance and rapidly revert to a susceptible state once the antibiotic is removed. Stated another way, exposure to bacteriostatic drugs selects for the evolution of heteroresistance in populations previously lacking this trait. More generally, our results question the definition of bacteriostasis as populations exposed to bacteriostatic drugs are replicating despite the lack of net growth.
Open AccessThe Evolution of Heteroresistance via Small Colony Variants in Escherichia coli Following Long Term Exposure to Bacteriostatic Antibiotics
Traditionally, bacteriostatic antibiotics are agents able to arrest bacterial growth. Despite being traditionally viewed as unable to kill bacterial cells, when they are used clinically the outcome of these drugs is frequently as effective as when a bactericidal drug is used. We explore the dynamics of Escherichia coli after exposure to two ribosome-targeting bacteriostatic antibiotics, chloramphenicol and azithromycin, for thirty days. The results of our experiments provide evidence that bacteria exposed to these drugs replicate, evolve, and generate a sub-population of small colony variants (SCVs) which are resistant to multiple drugs. These SCVs contribute to the evolution of heteroresistance and rapidly revert to a susceptible state once the antibiotic is removed. Stated another way, exposure to bacteriostatic drugs selects for the evolution of heteroresistance in populations previously lacking this trait. More generally, our results question the definition of bacteriostasis as populations exposed to bacteriostatic drugs are replicating despite the lack of net growth.
- Open Access
Theoretical Considerations and Empirical Predictions of the Pharmaco- and Population Dynamics of Heteroresistance
Background Antibiotics are considered one of the most important contributions to clinical medicine in the last 100 years. As a consequence of the use and overuse of these drugs, there have been increasing frequencies of infections with resistant pathogens. One form of resistance, heteroresistance, is particularly problematic; pathogens appear sensitive to a drug by commonly used susceptibility tests. However, upon exposure to the antibiotic, resistance rapidly ascends, and treatment fails. Methods We generate two distinct mathematical and computer-simulations models of heteroresistance to quantitatively explore the factors contributing to the emergence and ascent of resistance during treatment and the waning of resistance following cessation of treatment. We consider the factors that determine the response to antibiotic-mediated selection. In one model, heteroresistance is progressive, with each resistant state sequentially generating a higher resistance level. In the other model, heteroresistance is non-progressive, with a susceptible population directly generating populations with different resistance levels. Findings The conditions where resistance will ascend in the progressive model are narrower than those of the non-progressive model. The rate of reversion from the resistant to the sensitive states are critically dependent on the transition rates and the fitness cost of resistance. Our results demonstrate that the standard test used to identify heteroresistance is insufficient. The predictions of our models are consistent with empirical results. Interpretations Our results demand a reevaluation of the definition and criteria employed to identify heteroresistance. We recommend the definition of heteroresistance should include a consideration of the rate of return to susceptibility. Funding Funds for this study were provided by the U.S. National Institute of General Medical Sciences, the U.S. National Institute of Allergy and Infectious Diseases, and the Carlos III Institute of Health of Spain. Evidence before this study We searched Google Scholar for studies published before January 2023 for reviews, perspectives, and original articles (excluding case reports) of antibiotic heteroresistance to a variety of classes of antibiotics and numerous species of bacteria. We used a combination of search terms including “antibiotic heteroresistance”, “Population Analysis Profile test”, “molecular mechanisms”, “treatment failure” plus “modeling” and “theory”, with no language restrictions. Our particular focus was on finding theoretical and experimental papers that addressed the pharmaco-, population, and evolutionary dynamics of heteroresistance. We found many studies pertaining to the genetic mechanisms of heteroresistance but found only two studies of the pharmacodynamics of heteroresistance, and no studies on the population and evolutionary dynamics. Added value of this study Our mathematical modeling and computer-simulation study quantitatively explores two broadly different, previously undescribed, classes of heteroresistance. In our analysis, we give particular consideration to the response of heteroresistant populations to antibiotic exposure, focusing on the conditions where heteroresistance could lead to clinical treatment failure. We also provide novel consideration to the rate of reversion from a resistant to sensitive state. Implications of all the available evidence Our study identifies the broad conditions where heteroresistance may pose a risk for clinical treatment failure. Furthermore, our analysis demonstrates the need to consider the reversion rate from resistant to sensitive in the definition of heteroresistance and questions the sufficiency of the method currently used to identify heteroresistance.
Open AccessTheoretical Considerations and Empirical Predictions of the Pharmaco- and Population Dynamics of Heteroresistance
Background Antibiotics are considered one of the most important contributions to clinical medicine in the last 100 years. As a consequence of the use and overuse of these drugs, there have been increasing frequencies of infections with resistant pathogens. One form of resistance, heteroresistance, is particularly problematic; pathogens appear sensitive to a drug by commonly used susceptibility tests. However, upon exposure to the antibiotic, resistance rapidly ascends, and treatment fails. Methods We generate two distinct mathematical and computer-simulations models of heteroresistance to quantitatively explore the factors contributing to the emergence and ascent of resistance during treatment and the waning of resistance following cessation of treatment. We consider the factors that determine the response to antibiotic-mediated selection. In one model, heteroresistance is progressive, with each resistant state sequentially generating a higher resistance level. In the other model, heteroresistance is non-progressive, with a susceptible population directly generating populations with different resistance levels. Findings The conditions where resistance will ascend in the progressive model are narrower than those of the non-progressive model. The rate of reversion from the resistant to the sensitive states are critically dependent on the transition rates and the fitness cost of resistance. Our results demonstrate that the standard test used to identify heteroresistance is insufficient. The predictions of our models are consistent with empirical results. Interpretations Our results demand a reevaluation of the definition and criteria employed to identify heteroresistance. We recommend the definition of heteroresistance should include a consideration of the rate of return to susceptibility. Funding Funds for this study were provided by the U.S. National Institute of General Medical Sciences, the U.S. National Institute of Allergy and Infectious Diseases, and the Carlos III Institute of Health of Spain. Evidence before this study We searched Google Scholar for studies published before January 2023 for reviews, perspectives, and original articles (excluding case reports) of antibiotic heteroresistance to a variety of classes of antibiotics and numerous species of bacteria. We used a combination of search terms including “antibiotic heteroresistance”, “Population Analysis Profile test”, “molecular mechanisms”, “treatment failure” plus “modeling” and “theory”, with no language restrictions. Our particular focus was on finding theoretical and experimental papers that addressed the pharmaco-, population, and evolutionary dynamics of heteroresistance. We found many studies pertaining to the genetic mechanisms of heteroresistance but found only two studies of the pharmacodynamics of heteroresistance, and no studies on the population and evolutionary dynamics. Added value of this study Our mathematical modeling and computer-simulation study quantitatively explores two broadly different, previously undescribed, classes of heteroresistance. In our analysis, we give particular consideration to the response of heteroresistant populations to antibiotic exposure, focusing on the conditions where heteroresistance could lead to clinical treatment failure. We also provide novel consideration to the rate of reversion from a resistant to sensitive state. Implications of all the available evidence Our study identifies the broad conditions where heteroresistance may pose a risk for clinical treatment failure. Furthermore, our analysis demonstrates the need to consider the reversion rate from resistant to sensitive in the definition of heteroresistance and questions the sufficiency of the method currently used to identify heteroresistance.